Table 1 25-hydroxyvitamin D [25(OH)D] assessment in plasma. Concentration of 25(OH)D23 shown in groups established based on sex, season, age, disease severity, and hospitalization time. Data presented as medians with 25th and 75th quartiles in the brackets.

From: Association between 25(OH)D levels and clinical outcomes in patients infected with SARS-CoV-2: a cross-sectional study

25-hydroxyvitamin D [25(OH)D]

concentrations in plasma50

 

4.10

(2.78; 5.37)

 

Sex

Female

(n = 71)

Male

(n = 70)

p value

4.23

(3.13; 5.59)

3.82

(2.06; 5.20)

0.1712

Season

Spring/Summer

(n = 48)

Autumn/Winter

(n = 93)

p value

3.32

(2.02; 4.75)

3.92

(2.61; 5.15)

0.1824

Age

20–45 years

(n = 46)

45–70 years

(n = 69)

 > 70 years

(n = 26)

p value

4.13

(2.89; 5.54)

3.72

(2.21; 4.90)

4.79

(3.20; 5.90)

0.3951

Disease severity

Low

(n = 46)

Moderate

(n = 50)

High

(n = 45)

p value

4.43

(2.80; 6.20)

3.85

(2.24; 5.32)

3.98

(3.13; 5.55)

0.4695

Hospitalization time

 < 1 week

(n = 33)

1–2 weeks

(n = 62)

 > 2 weeks

(n = 46)

p value

4.52

(3.61; 6.31)

3.67

(2.11; 5.08)

3.72

(2.11; 4.94)

0.0342